Adherence to Varenicline and Associated Smoking Cessation in a Community-Based Patient Setting

BACKGROUND: Varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, is a pharmacotherapy indicated for smoking cessation treatment. To our knowledge, no studies have described varenicline treatment adherence and efficacy from real-world treatment patterns in a U.S. primary ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Liberman, Joshua N., Lichtenfeld, Marc J., Galaznik, Aaron, Mastey, Vera, Harnett, James, Zou, Kelly H., Leader, Joseph B., Kirchner, H. Lester
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437765/
https://www.ncbi.nlm.nih.gov/pubmed/23461428
http://dx.doi.org/10.18553/jmcp.2013.19.2.125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437765/
https://www.ncbi.nlm.nih.gov/pubmed/23461428
http://dx.doi.org/10.18553/jmcp.2013.19.2.125

Ejemplares similares